DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ENOXAPARIN SODIUM

« Back to Dashboard

All Clinical Trials for ENOXAPARIN SODIUM

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00191724	Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study	Completed	Eli Lilly and Company	Phase 2	2004-09-01	An exploratory, multicenter, randomized, placebo-controlled, double blind, dose escalation study comparing a standard therapy for submassive pulmonary embolism (Enoxaparin sodium) to a combined therapy of Drotrecogin alfa (activated) plus Enoxaparin sodium.
NCT00232271	The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.	Terminated	National Heart Foundation, Australia	Phase 4	2005-08-01	The purpose of this study is to assess the effect of the anticoagulant(blood thinner) Clexane on the development of leg clots following electrophysiology studies (EPS) and or radiofrequency ablation (RFA). People who suffer heart palpitations will sometimes need hospital admission to undergo an electrophysiology study ( and or a Radiofrequency Ablation)in order to diagnose and or treat their condition. Radiofrequency ablation is a procedure to stop abnormal heart rhythms. EPS/RFA studies require the puncture of the leg veins . Previous experience has shown that following the puncture of leg veins there is a small risk of developing a blood clot in the leg. It is not known whether giving blood thinners (anticoagulants) after the procedure will decrease this risk Enoxaparin Sodium (Clexane) is an anticoagulant used extensively and safely following bone (Orthopaedic) surgery to prevent blood clots from developing in the legs
NCT00232271	The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.	Terminated	Sanofi	Phase 4	2005-08-01	The purpose of this study is to assess the effect of the anticoagulant(blood thinner) Clexane on the development of leg clots following electrophysiology studies (EPS) and or radiofrequency ablation (RFA). People who suffer heart palpitations will sometimes need hospital admission to undergo an electrophysiology study ( and or a Radiofrequency Ablation)in order to diagnose and or treat their condition. Radiofrequency ablation is a procedure to stop abnormal heart rhythms. EPS/RFA studies require the puncture of the leg veins . Previous experience has shown that following the puncture of leg veins there is a small risk of developing a blood clot in the leg. It is not known whether giving blood thinners (anticoagulants) after the procedure will decrease this risk Enoxaparin Sodium (Clexane) is an anticoagulant used extensively and safely following bone (Orthopaedic) surgery to prevent blood clots from developing in the legs

Clinical Trial Conditions for ENOXAPARIN SODIUM

Condition Name

Condition Name for ENOXAPARIN SODIUM
Intervention	Trials
Venous Thromboembolism	12
Deep Vein Thrombosis	3
Thromboembolism	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ENOXAPARIN SODIUM
Intervention	Trials
Thromboembolism	15
Venous Thromboembolism	14
Venous Thrombosis	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ENOXAPARIN SODIUM

Trials by Country

Trials by Country for ENOXAPARIN SODIUM
Location	Trials
United States	22
Japan	7
Canada	7
Russian Federation	6
Brazil	5

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ENOXAPARIN SODIUM
Location	Trials
New Jersey	5
Ohio	3
District of Columbia	1
Massachusetts	1
Maryland	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ENOXAPARIN SODIUM

Clinical Trial Phase

Clinical Trial Phase for ENOXAPARIN SODIUM
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	15
Phase 2	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ENOXAPARIN SODIUM
Clinical Trial Phase	Trials
Completed	22
Recruiting	3
Terminated	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ENOXAPARIN SODIUM

Sponsor Name

Sponsor Name for ENOXAPARIN SODIUM
Sponsor	Trials
Sanofi	11
Daiichi Sankyo Co., Ltd.	4
Massachusetts General Hospital	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ENOXAPARIN SODIUM
Sponsor	Trials
Industry	22
Other	17

Export unavailable in trial.
Subscribe for complete access.